Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin: a Multicenter, Prospective, Observational Study in a Real World Setting

NCT03440788 is registered in ClinicalTrials.gov with Multinational Center for Quality of Life Research, Russia as lead sponsor.

NCT NCT03440788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03440788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-reported and Clinical Outcomes in Adults With Relapsed or Refractory Hodgkin's Lymphoma Receiving Brentuximab Vedotin: a Multicenter, Prospective, Observational Study in a Real World Setting
Lead sponsor
Multinational Center for Quality of Life Research, Russia
Phase
Observational
Overall status
Unknown status
Start date
April 2, 2018
Completion date
May 1, 2020
Enrollment
70 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed or refractory hodgkin's lymphoma